grisorixin has been researched along with Glioblastoma in 1 studies
*Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulahrouf, A; Defant, A; Khenaka, K; Leulmi, N; Mancini, I; Sighel, D | 1 |
1 other study(ies) available for grisorixin and Glioblastoma
| Article | Year |
|---|---|
Nigericin and grisorixin methyl ester from the Algerian soil-living Streptomyces youssoufiensis SF10 strain: a computational study on their epimeric structures and evaluation of glioblastoma stem cells growth inhibition.
Topics: Anti-Bacterial Agents; Cell Proliferation; Chromatography, High Pressure Liquid; Density Functional Theory; Glioblastoma; Humans; Molecular Structure; Nigericin; Spectrometry, Mass, Electrospray Ionization; Stem Cells; Stereoisomerism; Streptomyces; Tumor Cells, Cultured | 2019 |